Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Schwab US Dividend Equity ETF
SCHD
$104B
| $712K | ﹤0.01% |
29,817
-4,290
| -13% | -$109K |
|
602
Bruker
BRKR
$7.91B
| $711K | ﹤0.01% |
11,329
+200
| +2% | +$12.3K |
|
603
Duke Energy
DUK
$96.1B
| $705K | ﹤0.01% |
6,577
-13,770
| -68% | -$1.51M |
|
604
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $698K | ﹤0.01% |
9,481
-2,967
| -24% | -$231K |
|
605
Automatic Data Processing
ADP
$107B
| $678K | ﹤0.01% |
3,227
+1,069
| +50% | +$234K |
|
606
Ligand Pharmaceuticals
LGND
$6.07B
| $663K | ﹤0.01% |
11,912
-64
| -0.5% | -$3.63K |
|
607
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23B
| $659K | ﹤0.01% |
13,045
-856
| -6% | -$43.6K |
|
608
Vanguard Total International Bond ETF
BNDX
$82.3B
| $647K | ﹤0.01% |
13,052
-8,291
| -39% | -$418K |
|
609
Lennar Class B
LEN.B
$20.8B
| $642K | ﹤0.01% |
11,503
| – | – |
|
610
iShares Core S&P Small-Cap ETF
IJR
$113B
| $639K | ﹤0.01% |
6,916
+2,716
| +65% | +$270K |
|
611
M&T Bank
MTB
$36.5B
| $639K | ﹤0.01% |
+4,011
| New | +$674K |
|
612
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
| $634K | ﹤0.01% |
12,415
+1,189
| +11% | +$62K |
|
613
Casella Waste Systems
CWST
$5.71B
| $628K | ﹤0.01% |
8,643
-2,751
| -24% | -$209K |
|
614
Wells Fargo
WFC
$270B
| $628K | ﹤0.01% |
16,020
+2,039
| +15% | +$89.5K |
|
615
Truist Financial
TFC
$64.7B
| $626K | ﹤0.01% |
13,194
+5,383
| +69% | +$265K |
|
616
Aflac
AFL
$63.6B
| $624K | ﹤0.01% |
11,273
+7,609
| +208% | +$449K |
|
617
Labcorp
LH
$25.4B
| $620K | ﹤0.01% |
3,079
-70
| -2% | -$14.9K |
|
618
Fidelity MSCI Health Care Index ETF
FHLC
$3.32B
| $616K | ﹤0.01% |
10,146
+2,471
| +32% | +$153K |
|
619
iShares MSCI EAFE ETF
EFA
$79.6B
| $610K | ﹤0.01% |
9,766
-317
| -3% | -$21.6K |
|
620
Marathon Petroleum
MPC
$88B
| $605K | ﹤0.01% |
7,355
+412
| +6% | +$38.5K |
|
621
Open Text
OTEX
$6.29B
| $604K | ﹤0.01% |
15,955
-194
| -1% | -$7.68K |
|
622
Northrop Grumman
NOC
$78.8B
| $600K | ﹤0.01% |
1,254
-13
| -1% | -$5.97K |
|
623
Camden Property Trust
CPT
$11B
| $595K | ﹤0.01% |
4,427
+18
| +0.4% | +$2.67K |
|
624
Church & Dwight Co
CHD
$24.5B
| $583K | ﹤0.01% |
6,290
+70
| +1% | +$6.61K |
|
625
Organon & Co
OGN
$3.56B
| $581K | ﹤0.01% |
17,216
+231
| +1% | +$8.09K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.